BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1431 related articles for article (PubMed ID: 28035535)

  • 21. Gut-Microbiota-Brain Axis and Its Effect on Neuropsychiatric Disorders With Suspected Immune Dysregulation.
    Petra AI; Panagiotidou S; Hatziagelaki E; Stewart JM; Conti P; Theoharides TC
    Clin Ther; 2015 May; 37(5):984-95. PubMed ID: 26046241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain-gut-microbiota axis in Parkinson's disease.
    Mulak A; Bonaz B
    World J Gastroenterol; 2015 Oct; 21(37):10609-20. PubMed ID: 26457021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropeptides and the microbiota-gut-brain axis.
    Holzer P; Farzi A
    Adv Exp Med Biol; 2014; 817():195-219. PubMed ID: 24997035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abdominal pain in Irritable Bowel Syndrome: a review of putative psychological, neural and neuro-immune mechanisms.
    Elsenbruch S
    Brain Behav Immun; 2011 Mar; 25(3):386-94. PubMed ID: 21094682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microbiota-neuroimmune cross talk in stress-induced visceral hypersensitivity of the bowel.
    van Thiel IAM; de Jonge WJ; Chiu IM; van den Wijngaard RM
    Am J Physiol Gastrointest Liver Physiol; 2020 Jun; 318(6):G1034-G1041. PubMed ID: 32308040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gut/brain axis and the microbiota.
    Mayer EA; Tillisch K; Gupta A
    J Clin Invest; 2015 Mar; 125(3):926-38. PubMed ID: 25689247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mind-altering with the gut: Modulation of the gut-brain axis with probiotics.
    Kim N; Yun M; Oh YJ; Choi HJ
    J Microbiol; 2018 Mar; 56(3):172-182. PubMed ID: 29492874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The gut-brain axis in health neuroscience: implications for functional gastrointestinal disorders and appetite regulation.
    Weltens N; Iven J; Van Oudenhove L; Kano M
    Ann N Y Acad Sci; 2018 Sep; 1428(1):129-150. PubMed ID: 30255954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Probiotics: Potential novel therapeutics for microbiota-gut-brain axis dysfunction across gender and lifespan.
    Snigdha S; Ha K; Tsai P; Dinan TG; Bartos JD; Shahid M
    Pharmacol Ther; 2022 Mar; 231():107978. PubMed ID: 34492236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gutsy Moves: The Amygdala as a Critical Node in Microbiota to Brain Signaling.
    Cowan CSM; Hoban AE; Ventura-Silva AP; Dinan TG; Clarke G; Cryan JF
    Bioessays; 2018 Jan; 40(1):. PubMed ID: 29148060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Behavioural and neurochemical consequences of chronic gut microbiota depletion during adulthood in the rat.
    Hoban AE; Moloney RD; Golubeva AV; McVey Neufeld KA; O'Sullivan O; Patterson E; Stanton C; Dinan TG; Clarke G; Cryan JF
    Neuroscience; 2016 Dec; 339():463-477. PubMed ID: 27742460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gut-Brain-Microbiota Axis: Antibiotics and Functional Gastrointestinal Disorders.
    Karakan T; Ozkul C; Küpeli Akkol E; Bilici S; Sobarzo-Sánchez E; Capasso R
    Nutrients; 2021 Jan; 13(2):. PubMed ID: 33513791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Irritable Bowel Syndrome; gut microbiota and probiotic therapy].
    Tojo González R; Suarez Gonzalez A; Rúas Madiedo P; Mancebo Mata A; Pipa Muñiz M; Barreiro Alonso E; Roman Llorente FJ; Moro Villar MC; Arce González MM; Villegas Diaz MF; Mosquera Sierra E; Ruiz Ruiz M
    Nutr Hosp; 2015 Feb; 31 Suppl 1():83-8. PubMed ID: 25659060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current concepts in functional gastrointestinal disorders.
    Kovacic K
    Curr Opin Pediatr; 2015 Oct; 27(5):619-24. PubMed ID: 26208234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gut Microbiota: A Perspective for Psychiatrists.
    Rea K; Dinan TG; Cryan JF
    Neuropsychobiology; 2020; 79(1):50-62. PubMed ID: 31726457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Homeostasis of the gut barrier and potential biomarkers.
    Wells JM; Brummer RJ; Derrien M; MacDonald TT; Troost F; Cani PD; Theodorou V; Dekker J; Méheust A; de Vos WM; Mercenier A; Nauta A; Garcia-Rodenas CL
    Am J Physiol Gastrointest Liver Physiol; 2017 Mar; 312(3):G171-G193. PubMed ID: 27908847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gut microbiota and host metabolism in liver cirrhosis.
    Usami M; Miyoshi M; Yamashita H
    World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microbiota-gut-brain axis: Interaction of gut microbes and their metabolites with host epithelial barriers.
    Bhattarai Y
    Neurogastroenterol Motil; 2018 Jun; 30(6):e13366. PubMed ID: 29878576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gut microbiota, the pharmabiotics they produce and host health.
    Patterson E; Cryan JF; Fitzgerald GF; Ross RP; Dinan TG; Stanton C
    Proc Nutr Soc; 2014 Nov; 73(4):477-89. PubMed ID: 25196939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microbiota-Gut-Brain Axis: Modulator of Host Metabolism and Appetite.
    van de Wouw M; Schellekens H; Dinan TG; Cryan JF
    J Nutr; 2017 May; 147(5):727-745. PubMed ID: 28356427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 72.